Pharma Deals Review, Vol 2004, No 54 (2004)

Font Size:  Small  Medium  Large

Plexxikon and Wyeth Form Collaboration for PPAR Modulators

Business Review Editor

Abstract


Plexxikon has formed a multiproduct collaboration on the development Plexxikon’s PLX204 and other PPAR modulators with Wyeth Pharmaceuticals for treatments for diabetes and other metabolic disorders. The deal could worth up to US$372 M.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.